Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-02 Sale |
2025-04-02 8:34 pm |
Intra-Cellular Therapies Inc. | ITCI | Salas Eduardo Rene Director |
1,567 | $132 | $206,844 | 0 (Direct) |
View |
| 2025-04-02 Sale |
2025-04-02 5:47 pm |
Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director |
131,512 | $132 | $17,359,584 | 0 (Direct) |
View |
| 2025-04-02 Sale |
2025-04-02 5:46 pm |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael President |
21,307 | $132 | $2,812,524 | 25,374 (Direct) |
View |
| 2025-04-02 Sale |
2025-04-02 5:43 pm |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
11,340 | $132 | $1,496,880 | 0 (Direct) |
View |
| 2025-04-02 Sale |
2025-04-02 5:41 pm |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
52,811 | $132 | $6,971,052 | 21,876 (Direct) |
View |
| 2025-04-02 Sale |
2025-04-02 5:32 pm |
Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director |
58,238 | $132 | $7,687,416 | 0 (Indirect Direct) |
View |
| 2025-04-02 Sale |
2025-04-02 5:30 pm |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO |
1,135,235 | $132 | $149,851,020 | 75,682 (Indirect Direct) |
View |
| 2025-04-02 Sale |
2025-04-02 5:30 pm |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer |
42,913 | $132 | $5,664,516 | 21,876 (Direct) |
View |
| 2024-12-04 Sale |
2024-12-06 6:01 pm |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO |
102,697 | $84.93 | $8,722,501 | 1,122,026 (Direct) |
View |
| 2024-11-12 Sale |
2024-11-14 6:01 pm |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael President |
41,583 | $88.79 | $3,692,100 | 0 (Direct) |
View |
| 2024-08-29 Sale |
2024-08-30 6:01 pm |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO |
70,000 | $72.7 | $5,089,236 | 1,310,119 (Direct) |
View |
| 2024-08-26 Sale |
2024-08-28 6:00 pm |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO |
95,925 | $73.54 | $7,054,085 | 1,176,240 (Direct) |
View |
| 2024-08-21 Sale |
2024-08-23 6:00 pm |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO |
121,073 | $75.05 | $9,086,738 | 1,454,844 (Direct) |
View |
| 2024-08-16 Sale |
2024-08-20 6:03 pm |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
18,714 | $75.08 | $1,405,047 | 29,700 (Direct) |
View |
| 2024-06-24 Sale |
2024-06-25 6:04 pm |
Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director |
4,462 | $75.57 | $337,193 | 116,600 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-02 Option Award |
2025-04-02 5:46 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael President |
25,374 | $0 | 25,374 (Direct) |
View |
| 2025-04-02 Option Award |
2025-04-02 5:41 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
21,876 | $0 | 21,876 (Direct) |
View |
| 2025-04-02 Option Award |
2025-04-02 5:30 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO |
75,682 | $0 | 75,682 (Direct) |
View |
| 2025-04-02 Option Award |
2025-04-02 5:30 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer |
21,876 | $0 | 21,876 (Direct) |
View |
| 2025-03-26 Gift |
2025-03-31 6:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO |
190,000 | $0 | 1,135,235 (Direct) |
View |
| 2025-03-10 Tax Withholding |
2025-03-10 6:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer |
3,116 | $131.24 | 56,046 (Direct) |
View |
| 2025-03-06 Exercise |
2025-03-10 6:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer |
20,478 | $0 | 56,046 (Direct) |
View |
| 2025-03-06 Tax Withholding |
2025-03-10 6:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer |
5,572 | $131.19 | 56,046 (Direct) |
View |
| 2025-03-10 Tax Withholding |
2025-03-10 6:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO |
10,129 | $131.24 | 1,175,948 (Direct) |
View |
| 2025-03-06 Exercise |
2025-03-10 6:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO |
61,278 | $0 | 1,175,948 (Direct) |
View |
| 2025-03-06 Tax Withholding |
2025-03-10 6:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO |
19,848 | $131.19 | 1,175,948 (Direct) |
View |
| 2025-03-10 Tax Withholding |
2025-03-10 6:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
3,116 | $131.24 | 65,944 (Direct) |
View |
| 2025-03-06 Exercise |
2025-03-10 6:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
20,478 | $0 | 65,944 (Direct) |
View |
| 2025-03-06 Tax Withholding |
2025-03-10 6:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
5,572 | $131.19 | 65,944 (Direct) |
View |
| 2025-03-10 Tax Withholding |
2025-03-10 6:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael President |
3,757 | $131.24 | 34,440 (Direct) |
View |
| 2025-03-06 Exercise |
2025-03-10 6:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael President |
20,478 | $0 | 34,440 (Direct) |
View |
| 2025-03-06 Tax Withholding |
2025-03-10 6:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael President |
6,718 | $131.19 | 34,440 (Direct) |
View |
| 2025-03-01 Exercise |
2025-03-04 6:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO |
34,969 | $0 | 1,173,874 (Direct) |
View |
| 2025-03-01 Tax Withholding |
2025-03-04 6:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO |
16,978 | $128.2 | 1,173,874 (Direct) |
View |
| 2025-03-01 Exercise |
2025-03-04 6:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael President |
12,239 | $0 | 35,782 (Direct) |
View |
| 2025-03-01 Tax Withholding |
2025-03-04 6:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael President |
6,261 | $128.2 | 35,782 (Direct) |
View |
| 2025-03-01 Exercise |
2025-03-04 6:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
8,742 | $0 | 58,506 (Direct) |
View |
| 2025-03-01 Tax Withholding |
2025-03-04 6:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
3,709 | $128.2 | 58,506 (Direct) |
View |
| 2025-03-01 Exercise |
2025-03-04 6:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer |
8,742 | $0 | 48,608 (Direct) |
View |
| 2025-03-01 Tax Withholding |
2025-03-04 6:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer |
3,709 | $128.2 | 48,608 (Direct) |
View |
| 2025-02-24 Exercise |
2025-02-26 6:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director |
7,009 | $63.79 | 58,238 (Direct) |
View |
| 2025-02-24 Exercise |
2025-02-26 6:01 pm |
N/A 2033-06-22 |
Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director |
7,009 | $0 | 58,238 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-04 5:32 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO |
152,059 | $0 | 1,207,155 (Direct) |
View |
| 2025-01-31 Tax Withholding |
2025-02-04 5:32 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO |
15,233 | $127 | 1,207,155 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-04 5:31 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael President |
56,471 | $0 | 50,780 (Direct) |
View |
| 2025-01-31 Tax Withholding |
2025-02-04 5:31 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael President |
5,691 | $127 | 50,780 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-04 5:31 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
33,744 | $0 | 58,715 (Direct) |
View |
| 2025-01-31 Tax Withholding |
2025-02-04 5:31 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
4,729 | $127 | 58,715 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-04 5:29 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer |
35,638 | $0 | 50,711 (Direct) |
View |
| 2025-01-31 Tax Withholding |
2025-02-04 5:29 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer |
4,730 | $127 | 50,711 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-04 5:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Narula Sanjeev Executive Vice President & CFO |
22,727 | $0 | 22,727 (Direct) |
View |
| 2024-12-31 Option Award |
2025-01-03 6:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director |
215 | $83.52 | 131,512 (Direct) |
View |
| 2024-12-04 Exercise |
2024-12-06 6:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO |
102,697 | $12.73 | 1,122,026 (Direct) |
View |
| 2024-12-04 Exercise |
2024-12-06 6:01 pm |
N/A 2029-01-07 |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO |
102,697 | $0 | 1,122,026 (Direct) |
View |
| 2024-11-13 Exercise |
2024-11-14 6:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael President |
18,714 | $36.89 | 0 (Direct) |
View |
| 2024-11-12 Exercise |
2024-11-14 6:01 pm |
N/A 2030-02-17 |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael President |
41,583 | $0 | 0 (Direct) |
View |
| 2024-11-12 Exercise |
2024-11-14 6:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael President |
22,869 | $23.94 | 0 (Direct) |
View |
| 2024-09-30 Option Award |
2024-10-02 6:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director |
246 | $73.17 | 117,108 (Direct) |
View |
| 2024-08-29 Exercise |
2024-08-30 6:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO |
70,000 | $12.73 | 1,310,119 (Direct) |
View |
| 2024-08-29 Exercise |
2024-08-30 6:01 pm |
N/A 2029-01-07 |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO |
70,000 | $0 | 1,310,119 (Direct) |
View |
| 2024-08-26 Exercise |
2024-08-28 6:00 pm |
N/A 2025-01-02 |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO |
95,925 | $0 | 1,176,240 (Direct) |
View |
| 2024-08-26 Exercise |
2024-08-28 6:00 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO |
95,925 | $17.57 | 1,176,240 (Direct) |
View |
| 2024-08-21 Exercise |
2024-08-23 6:00 pm |
N/A 2025-01-02 |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO |
121,073 | $0 | 1,454,844 (Direct) |
View |
| 2024-08-21 Exercise |
2024-08-23 6:00 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO |
121,073 | $17.57 | 1,454,844 (Direct) |
View |
| 2024-08-16 Exercise |
2024-08-20 6:03 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
18,714 | $36.89 | 29,700 (Direct) |
View |
| 2024-08-16 Exercise |
2024-08-20 6:03 pm |
N/A 2031-02-22 |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
18,714 | $0 | 29,700 (Direct) |
View |
| 2024-08-12 Option Award |
2024-08-14 6:01 pm |
N/A 2034-08-11 |
Intra-Cellular Therapies Inc. | ITCI | Narula Sanjeev Executive Vice President & CFO |
52,297 | $0 | 52,297 (Direct) |
View |
| 2024-06-28 Option Award |
2024-07-02 8:00 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
83 | $68.49 | 11,340 (Direct) |
View |
| 2024-06-28 Option Award |
2024-07-02 8:00 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director |
262 | $68.49 | 116,862 (Direct) |
View |
| 2024-06-23 Exercise |
2024-06-25 6:05 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
1,567 | $0 | 11,257 (Direct) |
View |
| 2024-06-23 Exercise |
2024-06-25 6:05 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Salas Eduardo Rene Director |
1,567 | $0 | 1,567 (Direct) |
View |
| 2024-06-23 Exercise |
2024-06-25 6:05 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director |
1,567 | $0 | 51,229 (Direct) |
View |
| 2024-06-24 Exercise |
2024-06-25 6:04 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director |
20,000 | $16.86 | 116,600 (Direct) |
View |
| 2024-06-23 Exercise |
2024-06-25 6:04 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director |
21,567 | $0 | 116,600 (Direct) |
View |